DNA Nanostructure Serotype Detection Using Tandem Toehold Displacement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for dengue virus serotypes are laborious, require expensive equipment, and struggle with sensitivity and specificity, limiting their use in resource-limited settings and delaying appropriate medical management.
Innovation Solution
A system using DNA-nanostructures with specific hybridization regions and fluorophore-quencher pairs for dengue virus serotypes (DENV1-4) that employs tandem toehold-mediated displacement reactions (tTMDR) to amplify fluorescence signals, allowing for rapid and accurate serotype-specific detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If real-time RT-PCR is used for dengue virus detection, then diagnostic accuracy is improved, but equipment cost and operational complexity increase
Solution Approach 1:
The patent replaces the enzymatic amplification system of RT-PCR with a non-enzymatic toehold-mediated strand displacement reaction system. The detection mechanism transitions from enzyme-dependent DNA polymerase to enzyme-free nucleic acid strand displacement, eliminating the need for complex thermal cycling equipment while maintaining detection accuracy through sequence-specific hybridization and fluorophore-quencher signal transduction.
Solution Approach 2:
The patent employs disposable DNA nanodevices and fluorogenic probes that can be pre-packaged in simple formats. These single-use detection elements eliminate the need for expensive, reusable real-time PCR instruments and complex reagent preparations, making the system suitable for resource-limited settings while maintaining high diagnostic accuracy.
2Measurement precision
If cell culture method is used for dengue virus isolation, then serotype identification is achieved, but time consumption and labor requirements increase
Solution Approach 1:
The patent incorporates pre-designed DNA nanodevices with specific hybridization regions targeting conserved sequences of each dengue serotype. These devices are prepared in advance with integrated fluorophore-quencher systems, allowing direct detection of viral RNA upon patient sample introduction without requiring time-consuming cell culture propagation steps.
Solution Approach 2:
The patent extracts and amplifies only the specific nucleic acid sequences relevant for serotype identification using toehold-mediated strand displacement reactions. This targeted approach eliminates the need for full virus isolation and culture, directly detecting serotype-specific RNA sequences to achieve rapid identification.
3Productivity
If NS1 antigen detection is used for dengue diagnosis, then rapid testing is achieved, but sensitivity and specificity decrease
Solution Approach 1:
The patent replaces antibody-antigen recognition with nucleic acid hybridization-based detection. This substitution maintains the rapid testing capability of immunochromatographic methods while dramatically improving sensitivity and specificity through the higher binding affinity and sequence selectivity of nucleic acid complementary pairing.
Solution Approach 2:
The patent divides the detection system into multiple specialized DNA nanodevices, each targeting specific serotype sequences. This segmentation allows simultaneous detection of different dengue serotypes with high specificity, overcoming the cross-reactivity limitations of NS1 antigen detection while maintaining rapid testing throughput.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, sensitive, and accurate differentiation of dengue virus serotypes without the need for expensive equipment, improving clinical outcomes by facilitating timely medical management.
Implementation Method 1
each of the at least four DNA-nanostructures is operably linked to one of a fluorophore or a quencher selected from a fluorophore quencher pair, wherein the quencher is capable of quenching the fluorescent light emitted from the fluorophore
Implementation Method 2
the viral nucleic acid is capable of displacing the associated protector oligonucleotide and hybridizing to the DNA-nanostructure
Implementation Method 3
the associated capture oligonucleotide is capable of displacing the viral nucleic acid and hybridizing to the DNA-nanostructure
Data Source
AI summary
Described herein are systems and methods that may be used to differentially detect viral serotype specific nucleic acid. For example, these systems may comprise multiple DNA-nanostructures, capture oligonucleotides and protector oligonucleotides, wherein each DNA-nanostructure and its associated capture oligonucleotide and protector oligonucleotide are specific for a unique viral type or serotype.